449 related articles for article (PubMed ID: 15106259)
21. Implications of the study population in the early evaluation of anticholinesterase inhibitors for Alzheimer's disease.
Cutler NR; Sramek JJ; Murphy MF; Nash RJ
Ann Pharmacother; 1992 Sep; 26(9):1118-22. PubMed ID: 1421679
[TBL] [Abstract][Full Text] [Related]
22. Galantamine for vascular cognitive impairment.
Birks J; Craig D
Cochrane Database Syst Rev; 2006 Jan; (4):CD004746. PubMed ID: 23862185
[TBL] [Abstract][Full Text] [Related]
23. Selegiline for Alzheimer's disease.
Birks J; Flicker L
Cochrane Database Syst Rev; 2003; (1):CD000442. PubMed ID: 12535396
[TBL] [Abstract][Full Text] [Related]
24. Double-blind placebo-controlled study of velnacrine in Alzheimer's disease.
Zemlan FP; Keys M; Richter RW; Strub RL
Life Sci; 1996; 58(21):1823-32. PubMed ID: 8637408
[TBL] [Abstract][Full Text] [Related]
25. Tacrine for Alzheimer's disease.
Qizilbash N; Birks J; Lopez Arrieta J; Lewington S; Szeto S
Cochrane Database Syst Rev; 2000; (3):CD000202. PubMed ID: 10908463
[TBL] [Abstract][Full Text] [Related]
26. Memantine for dementia.
Areosa SA; Sherriff F
Cochrane Database Syst Rev; 2003; (1):CD003154. PubMed ID: 12535459
[TBL] [Abstract][Full Text] [Related]
27. Donepezil for vascular cognitive impairment.
Malouf R; Birks J
Cochrane Database Syst Rev; 2004; (1):CD004395. PubMed ID: 14974068
[TBL] [Abstract][Full Text] [Related]
28. Huperzine A for Alzheimer's disease.
Li J; Wu HM; Zhou RL; Liu GJ; Dong BR
Cochrane Database Syst Rev; 2008 Apr; (2):CD005592. PubMed ID: 18425924
[TBL] [Abstract][Full Text] [Related]
29. Vitamin E for Alzheimer's disease and mild cognitive impairment.
Isaac MG; Quinn R; Tabet N
Cochrane Database Syst Rev; 2008 Jul; (3):CD002854. PubMed ID: 18646084
[TBL] [Abstract][Full Text] [Related]
30. Rivastigmine for vascular cognitive impairment.
Birks J; McGuinness B; Craig D
Cochrane Database Syst Rev; 2013 May; (5):CD004744. PubMed ID: 23728651
[TBL] [Abstract][Full Text] [Related]
31. Donepezil for mild cognitive impairment.
Birks J; Flicker L
Cochrane Database Syst Rev; 2006 Jul; (3):CD006104. PubMed ID: 16856114
[TBL] [Abstract][Full Text] [Related]
32. Memantine for dementia.
Areosa SA; Sherriff F
Cochrane Database Syst Rev; 2003; (3):CD003154. PubMed ID: 12917950
[TBL] [Abstract][Full Text] [Related]
33. Galantamine for Alzheimer's disease.
Loy C; Schneider L
Cochrane Database Syst Rev; 2004 Oct; (4):CD001747. PubMed ID: 15495017
[TBL] [Abstract][Full Text] [Related]
34. Folic acid with or without vitamin B12 for cognition and dementia.
Malouf M; Grimley EJ; Areosa SA
Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.
Fioravanti M; Flicker L
Cochrane Database Syst Rev; 2001; 2001(4):CD003159. PubMed ID: 11687175
[TBL] [Abstract][Full Text] [Related]
36. Galantamine for vascular cognitive impairment.
Craig D; Birks J
Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD004746. PubMed ID: 16437493
[TBL] [Abstract][Full Text] [Related]
37. Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration.
Qizilbash N; Whitehead A; Higgins J; Wilcock G; Schneider L; Farlow M
JAMA; 1998 Nov; 280(20):1777-82. PubMed ID: 9842955
[TBL] [Abstract][Full Text] [Related]
38. Cholinesterase inhibitors for rarer dementias associated with neurological conditions.
Li Y; Hai S; Zhou Y; Dong BR
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009444. PubMed ID: 25734590
[TBL] [Abstract][Full Text] [Related]
39. Nimodipine for primary degenerative, mixed and vascular dementia.
López-Arrieta JM; Birks J
Cochrane Database Syst Rev; 2002; (3):CD000147. PubMed ID: 12137606
[TBL] [Abstract][Full Text] [Related]
40. Cholinesterase inhibitors for Parkinson's disease dementia.
Maidment I; Fox C; Boustani M
Cochrane Database Syst Rev; 2006 Jan; (1):CD004747. PubMed ID: 16437494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
